Lotus Eye Hospital and Institute Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Lotus Eye Hospital and Institute.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare winstgroei | 26.4% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Lotus Eye Hospital and Institute onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 485 | 22 | N/A | N/A | N/A |
| 3/31/2024 | 482 | 29 | 0 | 57 | N/A |
| 12/31/2023 | 485 | 35 | N/A | N/A | N/A |
| 9/30/2023 | 486 | 40 | -1 | 57 | N/A |
| 6/30/2023 | 477 | 41 | N/A | N/A | N/A |
| 3/31/2023 | 470 | 41 | 13 | 44 | N/A |
| 12/31/2022 | 464 | 40 | N/A | N/A | N/A |
| 9/30/2022 | 459 | 42 | 13 | 69 | N/A |
| 6/30/2022 | 449 | 46 | N/A | N/A | N/A |
| 3/31/2022 | 389 | 30 | -3 | 44 | N/A |
| 12/31/2021 | 389 | 36 | N/A | N/A | N/A |
| 9/30/2021 | 372 | 32 | 37 | 49 | N/A |
| 6/30/2021 | 335 | 20 | N/A | N/A | N/A |
| 3/31/2021 | 324 | 16 | 23 | 27 | N/A |
| 12/31/2020 | 300 | -5 | N/A | N/A | N/A |
| 9/30/2020 | 301 | -14 | 8 | 26 | N/A |
| 6/30/2020 | 335 | -6 | N/A | N/A | N/A |
| 3/31/2020 | 406 | 11 | 26 | 50 | N/A |
| 12/31/2019 | 420 | 21 | N/A | N/A | N/A |
| 9/30/2019 | 415 | 20 | N/A | N/A | N/A |
| 6/30/2019 | 401 | 11 | N/A | N/A | N/A |
| 3/31/2019 | 384 | 7 | -5 | 42 | N/A |
| 12/31/2018 | 382 | 7 | N/A | N/A | N/A |
| 9/30/2018 | 381 | 9 | N/A | N/A | N/A |
| 6/30/2018 | 384 | 14 | N/A | N/A | N/A |
| 3/31/2018 | 380 | 17 | N/A | 58 | N/A |
| 12/31/2017 | 373 | 8 | N/A | N/A | N/A |
| 9/30/2017 | 359 | 4 | N/A | N/A | N/A |
| 6/30/2017 | 350 | 6 | N/A | N/A | N/A |
| 3/31/2017 | 340 | 4 | N/A | 30 | N/A |
| 12/31/2016 | 330 | 7 | N/A | N/A | N/A |
| 9/30/2016 | 324 | 7 | N/A | N/A | N/A |
| 6/30/2016 | 314 | 0 | N/A | N/A | N/A |
| 3/31/2016 | 311 | 1 | N/A | 34 | N/A |
| 12/31/2015 | 311 | -5 | N/A | N/A | N/A |
| 9/30/2015 | 315 | -6 | N/A | N/A | N/A |
| 6/30/2015 | 308 | -14 | N/A | N/A | N/A |
| 3/31/2015 | 302 | -20 | N/A | 24 | N/A |
| 12/31/2014 | 298 | -12 | N/A | N/A | N/A |
| 9/30/2014 | 290 | -9 | N/A | N/A | N/A |
| 6/30/2014 | 289 | 1 | N/A | N/A | N/A |
| 3/31/2014 | 288 | 0 | N/A | 44 | N/A |
| 12/31/2013 | 287 | 4 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if LOTUSEYE's forecast earnings growth is above the savings rate (6.7%).
Winst versus markt: Insufficient data to determine if LOTUSEYE's earnings are forecast to grow faster than the Indian market
Hoge groeiwinsten: Insufficient data to determine if LOTUSEYE's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if LOTUSEYE's revenue is forecast to grow faster than the Indian market.
Hoge groei-inkomsten: Insufficient data to determine if LOTUSEYE's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if LOTUSEYE's Return on Equity is forecast to be high in 3 years time